GeneBioHealth key facts
- Provider of in vitro diagnostic and health-focused biotechnology services intended for supporting early detection and clinical testing.
- It has raised $15.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Guangdong Yuecai Venture Capital, Fuho Capital, Zhongshan Xiwan Investment Holding Development, Hengbang Capital, Shaanxi Tour Group — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch GeneBioHealth: the Monday email on marks, rounds and moves
GeneBioHealth funding rounds
No funding rounds for GeneBioHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
GeneBioHealth investors
6 investors are on record for GeneBioHealth, including Guangdong Yuecai Venture Capital, Fuho Capital, Zhongshan Xiwan Investment Holding Development and Hengbang Capital.
About GeneBioHealth
Provider of in vitro diagnostic and health-focused biotechnology services intended for supporting early detection and clinical testing. The company offers research and development capabilities, controlled manufacturing, diagnostic reagent and instrument production, clinical laboratory services, and health-related testing support, enabling medical professionals, clinical laboratories, and healthcare institutions to enhance patient care outcomes across preventive and clinical settings.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2013
- Employees
- 57
- Website
- genebiohealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
GeneBioHealth doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.